Genie Biotech EU - Company finances
|
EUR
|
2020
From: 2020-08-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | - | 4,185 | 0 | 17,225 | 25,091 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity | 15,116 | 4,049 | 33,135 | 50,215 | 61,842 | 41,897 |
| Liabilities | 3,905 | 3,900 | 12,642 | 10,792 | 4,747 | 10,387 |
| Non-current assets | 0 | 0 | 26,836 | 46,362 | 45,849 | 46,471 |
| Current assets | 19,021 | 7,949 | 18,941 | 11,904 | 17,877 | 5,568 |
| Total assets | 19,021 | 7,949 | 45,777 | 58,266 | 63,726 | 52,039 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 9,972 | 12,462 | 11,564 |
| Social insurance contributions | - | - | - | - | 15,435 | 15,718 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | - | +45.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 0.0% | - | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 0.0% | - | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 1.0 | 0.4 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 2,643 | - | 4,306 | 6,273 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Genie Biotech EU - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-18 | 1496.17 |
Genie Biotech EU - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Genie Biotech EU, UAB (code 305529882) is a Private Limited Liability Company engaged in research and experimental development on other natural sciences and engineering. In the latest financial year, 2025, the company generated revenue of €25.1K, up from €17.2K in 2024, which indicates solid year-on-year growth of 45.7%. The balance sheet remained modest in scale, with total assets of €52.0K at the end of 2025, compared with €63.7K a year earlier. Equity stood at €41.9K and liabilities at €10.4K, while long-term assets amounted to €46.5K and short-term assets to €5.6K. The reported equity ratio was 80.5%, debt-to-equity was 0.25, and asset turnover was 0.48x. Revenue per employee was €6.3K, suggesting a small operating base. Overall, the 2025 figures point to a company with rising turnover, a strong equity position, and relatively limited leverage.